National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

lidocaine patch 5%
A transdermal patch containing a 5 percent aqueous base solution of the synthetic amide-type anesthetic lidocaine with analgesic activity. Upon topical application and transdermal delivery, the active ingredient lidocaine binds to and blocks voltage-gated sodium channels in the neuronal cell membrane; lidocaine-mediated stabilization of neuronal membranes inhibits the initiation and conduction of nerve impulses and produces a reversible local anesthesia. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Lidoderm



Previous:lexatumumab, liarozole fumarate, Liazal, licorice root extract, lidocaine
Next:Lidoderm, Lidothesin, Linfolizin, Linomide, lintuzumab

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov